Literature DB >> 9603479

IL-10-mediated suppression of TNF-alpha production is independent of its ability to inhibit NF kappa B activity.

C J Clarke1, A Hales, A Hunt, B M Foxwell.   

Abstract

IL-10 has a well-characterized anti-inflammatory role that includes the suppression of inflammatory cytokine (e.g. TNF-alpha) production by monocytic/macrophage cells. Both transcriptional and post-transcriptional/translational mechanisms have been proposed to explain this process. In this study we observed that IL-10 inhibited nuclear NF kappa B DNA binding activity without affecting I kappa B degradation or translocation of NF kappa B subunits to the nucleus. While the suppression of NF kappa B in 70Z/3 pre-B cells correlated with suppression of NF kappa B transcriptional activity and expression of surface IgM, it did not correlate with the production of TNF-alpha mRNA or protein in RAW 264.7 macrophages. Similar observations in the macrophages were made with a second anti-inflammatory cytokine, IL-4. Therefore we conclude that although IL-10 or IL-4 can suppress NF kappa B activity, this appears to have little effect on the expression of the TNF-alpha gene and is unlikely to be the basis of the anti-inflammatory effects of these cytokines.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9603479     DOI: 10.1002/(SICI)1521-4141(199805)28:05<1719::AID-IMMU1719>3.0.CO;2-Q

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  52 in total

1.  IL-10 enhances IL-2-induced proliferation and cytotoxicity by human intestinal lymphocytes.

Authors:  E C Ebert
Journal:  Clin Exp Immunol       Date:  2000-03       Impact factor: 4.330

Review 2.  Sepsis-induced immunosuppression: from bad to worse.

Authors:  R C Reddy; G H Chen; P K Tekchandani; T J Standiford
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

3.  Alleviation of heat stress by Chlorophytum borivilianum: impact on stress markers, antioxidant, and immune status in crossbred cows.

Authors:  Pooja Devi; Mahendra Singh; Yallappa M Somagond; Anjali Aggarwal
Journal:  Trop Anim Health Prod       Date:  2021-06-08       Impact factor: 1.559

4.  Passive heat therapy protects against endothelial cell hypoxia-reoxygenation via effects of elevations in temperature and circulating factors.

Authors:  Vienna E Brunt; Karen Wiedenfeld-Needham; Lindan N Comrada; Christopher T Minson
Journal:  J Physiol       Date:  2018-09-12       Impact factor: 5.182

5.  Immunosuppressive effects of red blood cells on monocytes are related to both storage time and storage solution.

Authors:  Jennifer Muszynski; Jyotsna Nateri; Kathleen Nicol; Kristin Greathouse; Lisa Hanson; Mark Hall
Journal:  Transfusion       Date:  2011-10-07       Impact factor: 3.157

6.  A functional role for eicosanoid-lysophospholipids in activating monocyte signaling.

Authors:  Gao-Yuan Liu; Sung Ho Moon; Christopher M Jenkins; Harold F Sims; Shaoping Guan; Richard W Gross
Journal:  J Biol Chem       Date:  2020-07-08       Impact factor: 5.157

Review 7.  Interleukin-10 and chronic liver disease.

Authors:  Li-Juan Zhang; Xiao-Zhong Wang
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

8.  Pro- and anti-inflammatory cytokine responses to a 164-km road cycle ride in a hot environment.

Authors:  Hui-Ying Luk; Danielle E Levitt; Elaine C Lee; Matthew S Ganio; Brendon P McDermott; Brian R Kupchak; Brian K McFarlin; David W Hill; Lawrence E Armstrong; Jakob L Vingren
Journal:  Eur J Appl Physiol       Date:  2016-08-13       Impact factor: 3.078

9.  ABIN-3: a molecular basis for species divergence in interleukin-10-induced anti-inflammatory actions.

Authors:  Brian K Weaver; Erwin Bohn; Barbi A Judd; M Pilar Gil; Robert D Schreiber
Journal:  Mol Cell Biol       Date:  2007-05-07       Impact factor: 4.272

10.  Molecular mechanisms of interleukin-10-mediated inhibition of NF-kappaB activity: a role for p50.

Authors:  F Driessler; K Venstrom; R Sabat; K Asadullah; A J Schottelius
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.